Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Szára, S |
Dimethyltryptamin: Its Metabolism in Man the Relation of its Psychotic... |
Experientia |
1956 |
Szara S |
The comparison of the psychotic effect of tryptamine derivatives with ... |
Psychotropic drugs |
1957 |
Cohen S |
A classification of LSD complications |
Psychosomatics |
1966 |
Welsum RA |
A simplified procedure for the identification of drugs from the illici... |
J. Chromat. |
1973 |
Haefely W |
The Effects of 5-Hydroxytryptamine and Some Related Compounds on the C... |
Naunyn-Schmiedeberg'... |
1974 |
Halki JJ |
The effects of Dextroamphetamine, Dimethyltryptamine, Lysergic Acid Di... |
Dissertation Abstr I... |
1974 |
Siegal RK, Brewster JM, J... |
An Obsservational Study of Hallucinogen-Induced Behavior in Unrestrain... |
Psychopharmacologia |
1974 |
Rappoport M, Cornish H |
The Effect of Two Hallucinogens on in Vivo Concentrations of Cyclic AM... |
Toxicol. appl. Pharm... |
1974 |
Marquis W J |
A Behavioral Analysis of Hallucinogenic Drugs |
Dissertation Abstr. ... |
1975 |
Pickworth WB, Sharpe LG |
The Transcallosally Evoked Potential (TEP) Following Administration Of... |
Fed.Proc. |
1976 |
Siegel RK, Brewster JM, J... |
The Effects of Hallucinogens On Blind Monkeys |
Intern.Pharmacopsych... |
1976 |
Rosengarten H, Friedhoff ... |
A review of recent studies of the biosynthesis and excretion of halluc... |
Schizophr Bull |
1976 |
Bedard P, Pycock CJ |
'Wet-Dog'Behaviour in the Rat: A Possible Quantitative Model of Centra... |
Neuropharmacology |
1977 |
Hsu LL, Paul SM, Halaris ... |
Rat Brain Aryl Acylamidase: Multiple Forms and Inhibition Effects of L... |
Life Sci. |
1977 |
Vogel WH, Evans BD |
Structure-Activity-Relationship Of Certain Hallucinogenic Substances B... |
Life Sci. |
1977 |
Waldmeier PC, Maître L |
Neurochemical Investigations of the Interaction of N,N-Dimethyltryptam... |
Psychopharmacology |
1977 |
Geyer MA, Petersen LR, Ro... |
The effects of lysergic acid diethylamide and mescaline-derived halluc... |
J.Pharmacol.Exp.Ther... |
1978 |
Schlemmer RF, Tyler CB, N... |
The Comparitive Effects Of LSD, Mescaline, And DMT On Primate Social A... |
Federation Proceedin... |
1978 |
Trulson NE, Jacobs BL |
Behavioral Evidence for Denervation Supersensitivity After Destruction... |
Ann.N.Y.Acad.Sci. |
1978 |
Vaupel DB, Martin WR |
LSD-like Hallucinogens In The Dog: Validation Studies With Mescaline (... |
Fed. Proc. |
1978 |
Freedman DX |
LSD, Psychotogenic Procedures, and Brain Neurohumors |
Psychopharmacol.Bull... |
1979 |
Glennon RA, Rosecrans JA,... |
Hallucinogens As A Discriminative Stimuli: Generalizations Of Dom To A... |
Life Sci. |
1979 |
Carter MF, Shulgin AT |
N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptami... |
Commun Psychopharmac... |
1980 |
Commissaris RL, Lyness WH... |
Antagonism of the Behavioral Effects of Hallucinogens by the 5-Hydroxy... |
Pharmacologist |
1980 |
Sloviter RS, Drust EG, Da... |
Serotonergic Mediation Of Behavioral Effects In Rats Of Indoles And Ph... |
Federation Proc. |
1980 |
Lucki I, Frazer A |
Prevention of the Serotonin Syndrome in Rats by Repeated Administratio... |
Psychopharmacology |
1982 |
McKenna DJ, Towers GH, Ab... |
Monoamine oxidase inhibitors in South American hallucinogenic plants: ... |
J Ethnopharmacol |
1984 |
MacRae WD, Towers GH |
Justicia pectoralis: a study of the basis for its use as a hallucinoge... |
J Ethnopharmacol |
1984 |
Adams LM, Geyer MA |
Effects of DOM and DMT in a proposed animal model of hallucinogenic ac... |
Prog Neuropsychophar... |
1985 |
Mack JP, Mulvena DP, Slay... |
N,N-Dimethyltryptamine Production in Phalaris aquatica Seedlings: A Ma... |
Plant Physiol |
1988 |
Sadzot B, Baraban JM, Gle... |
Hallucinogenic drug interactions at human brain 5-HT2 receptors: impli... |
Psychopharmacology (... |
1989 |
Carvey P, Nausieda P, Wee... |
LSD and other related hallucinogens elicit myoclonic jumping behavior ... |
Prog Neuropsychophar... |
1989 |
Davis W, Weil AT |
Identity of a new world psychoactive toad |
Ancient Mesoamerica |
1992 |
Weil AT, Davis W |
Bufo alvarius: a potent hallucinogen of animal origin |
J Ethnopharmacol |
1994 |
Strassman RJ, Qualls CR, ... |
Dose-response study of N,N-dimethyltryptamine in humans. II. Subjectiv... |
Arch Gen Psychiatry |
1994 |
Strassman RJ, Qualls CR |
Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendoc... |
Arch Gen Psychiatry |
1994 |
Szara S |
Are Hallucinogens Psychoheuristic? |
NIDA Research Monogr... |
1994 |
Strassman RJ, Qualls CR, ... |
Differential tolerance to biological and subjective effects of four cl... |
Biol Psychiatry |
1996 |
Halpern JH |
The Use of Hallucinogens in the Treatment of Addiction |
Addiction Research |
1996 |
Callaway JC, Raymon LP, H... |
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human ... |
J Anal Toxicol |
1996 |
Strassman RJ |
Human psychopharmacology of N,N-dimethyltryptamine |
Behav Brain Res |
1996 |
Matsumoto K, Mizowaki M, ... |
Suppressive effect of mitragynine on the 5-methoxy-N,N-dimethyltryptam... |
Pharmacol Biochem Be... |
1997 |
Schechter MD |
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-... |
Life Sci |
1997 |
Ott J |
Pharmahuasca, Anahuasca and Vinho da Jurema: Human Pharmacology of Ora... |
Yearbook for Ethnome... |
1997 |
Smith RL, Canton H, Barre... |
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5... |
Pharmacol Biochem Be... |
1998 |
Callaway JC, McKenna DJ, ... |
Pharmacokinetics of Hoasca alkaloids in healthy humans |
J Ethnopharmacol |
1999 |
Winter JC, Helsley S, Fio... |
The acute effects of monoamine reuptake inhibitors on the stimulus eff... |
Pharmacol Biochem Be... |
1999 |
West WB, Lou A, Pechersky... |
Antagonism of a PCP drug discrimination by hallucinogens and related d... |
Neuropsychopharmacol... |
2000 |
Riba J, Rodriguez-Fornel... |
Subjective effects and tolerability of the South American psychoactive... |
Psychopharmacology (... |
2001 |
Riba J, Rodriguez-Fornel... |
Psychometric assessment of the Hallucinogen Rating Scale |
Drug Alcohol Depend |
2001 |
Riba J, Anderer P, Morte ... |
Topographic pharmaco-EEG mapping of the effects of the South American ... |
Br J Clin Pharmacol |
2002 |
Riba J, Rodriguez-Fornel... |
Effects of ayahuasca on sensory and sensorimotor gating in humans as m... |
Psychopharmacology (... |
2002 |
Riba J, Valle M, Urbano G... |
Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects... |
J Pharmacol Exp Ther |
2003 |
Brush DE, Bird SB, Boyer ... |
Monoamine oxidase inhibitor poisoning resulting from Internet misinfor... |
J Toxicol Clin Toxic... |
2004 |
Sessa B |
Can psychedelics have a role in psychiatry once again? |
Br J Psychiatry |
2005 |
Fantegrossi WE, Harringto... |
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mi... |
Pharmacol Biochem Be... |
2006 |
Snyder SH |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
Callaway JC, Grob CS, McK... |
A demand for clarity regarding a case report on the ingestion of 5-met... |
J Anal Toxicol |
2006 |
Gable RS |
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and har... |
Addiction |
2007 |
Rodriguez, M.A. |
A Methodology for Studying Various Interpretations of the N,N-dimethyl... |
Journal of Scientifi... |
2007 |
Szára S |
DMT at fifty |
Neuropsychopharmacol... |
2007 |
Chen BH, Liu JT, Chen WX,... |
A general approach to the screening and confirmation of tryptamines an... |
Talanta |
2008 |
Brandt SD, Martins CP, Fr... |
N,N-Dimethyltryptamine and dichloromethane: rearrangement of quaternar... |
J Pharm Biomed Anal |
2008 |
Tupper KW |
Entheogenic healing: The spiritual effects and therapeutic potential o... |
Book: The Healing Po... |
2009 |
Gatch MB, Forster MJ, Jan... |
Abuse Liability Profile of Three Substituted Tryptamines |
J Pharmacol Exp Ther |
2011 |
Dos Santos RG, Valle M, B... |
Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca: A C... |
J Clin Psychopharmac... |
2011 |
Bruno R, Matthews AJ, Dun... |
Emerging psychoactive substance use among regular ecstasy users in Aus... |
Drug Alcohol Depend |
2011 |
Coyle JR, Presti DE, Bagg... |
Quantitative Analysis of Narrative Reports of Psychedelic Drugs |
arXiv.org : Quantita... |
2012 |
Barker SA, McIlhenny EH, ... |
A critical review of reports of endogenous psychedelic N, N-dimethyltr... |
Drug Test Anal |
2012 |
Bouso JC, González D, Fon... |
Personality, Psychopathology, Life Attitudes and Neuropsychological Pe... |
PLoS ONE |
2012 |
Bouso JC, Palhano-Fontes ... |
Long-term use of psychedelic drugs is associated with differences in b... |
Eur Neuropsychopharm... |
2015 |
Jiang XL, Shen HW, Yu AM |
Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia ... |
Neuropharmacology |
2015 |
Szabo A |
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Op... |
Front Immunol |
2015 |
Araújo AM, Carvalho F, Ba... |
The hallucinogenic world of tryptamines: an updated review |
Arch Toxicol |
2015 |
Carbonaro TM, Gatch MB |
Neuropharmacology of N,N-dimethyltryptamine |
Brain Res Bull |
2016 |
Nunes AA, Dos Santos RG, ... |
Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systemati... |
J Psychoactive Drugs |
2016 |
Palma-Conesa ÁJ, Ventura ... |
Something New about Something Old: A 10-Year Follow-Up on Classical an... |
J Psychoactive Drugs |
2017 |
Al-Imam A |
Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A... |
Case Reports in Neur... |
2017 |
St John G |
The Breakthrough Experience: DMT Hyperspace and its Liminal Aesthetics |
Anthropology of Cons... |
2018 |
Davis AK, Barsuglia JP, L... |
The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use:... |
J Psychopharmacol |
2018 |
Barsuglia JP, Polanco M, ... |
A case report SPECT study and theoretical rationale for the sequential... |
Prog Brain Res |
2018 |
Martial C, Cassol H, Char... |
Neurochemical models of near-death experiences: a large-scale study ba... |
Conscious Cogn |
2019 |
Cozzi NV, Daley PF |
Synthesis and characterization of high-purity N,N-dimethyltryptamine h... |
Drug Test Anal |
2020 |
Sherwood AM, Claveau R, L... |
Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use |
ACS Omega |
2020 |